Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U ...

The first-line laser treatment for glaucoma and ocular hypertension will be unveiled at the 2025 American Glaucoma Society ...

Traditional SLT involves using a laser to manipulate the eye's trabecular meshwork, located around the base of the cornea, ...

Alcon (ALC) announced he full U.S. commercial availability of Voyager DSLT, the first and only Direct Selective Laser Trabeculoplasty device .

Analysts on Wall Street project that Alcon (ALC) will announce quarterly earnings of $0.70 per share in its forthcoming report, representing no change year over year. Revenues are projected to reach ...

Bolivia's Vice Minister of Communication Gabriela Alcón said this week that spreading misinformation about lithium contracts ...

消息面上，欧康维视生物此前公告，预计2024年度实现收益为4.08至4.2亿元，同比增长65.6%至70.5%。主要由于公司完成了对爱尔康转让产品的收购及获许可产品的授权引进，显著提升公司的收益规模，以及销售其他眼科医药产品产生的收益大幅增加。

3 “Alcon is dedicated to developing treatments and technologies for people living with glaucoma,” said Terry Kim, MD, Chief Medical Officer and Head of Global Medical Safety, Alcon.

Analysts on Wall Street project that Alcon (ALC) will announce quarterly earnings of $0.70 per share in its forthcoming report, representing no change year over year. Revenues are projected to ...

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager ...